Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Vitamin E

This article was originally published in The Tan Sheet

Executive Summary

Vitamin E: American Heart Association names vitamin E fourth of top 10 cardiovascular research advances in 1996 because the supplement appears to prevent coronary heart disease. AHA points to several 1996 published studies that "lend credence" to the antioxidant's role in preventing oxygen in blood from combining with low-density lipoprotein cholesterol ("bad cholesterol"), one of the contributors to plaque in coronary arteries. Specifically, the association points to a 2,000-patient study published in the March 22 issue of The Lancet where vitamin E supplementation reduced myocardial infarcts by 75% ("The Tan Sheet" March 25, 1996, p. 11). Additionally, AHA points to a study published in the May 2 issue of the New England Journal of Medicine that examined vitamin E in foods given to protect postmenopausal women dying of heart disease ("The Tan Sheet" May 6, 1996, p. 14)...

You may also be interested in...



People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

PS086555

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel